Özgür ALTUN, Yücel ARMAN, Murat AKARSU, Tufan TUKEK, Nur KARAKÜTÜK YÜZTAŞ, Selay ARSLAN, Ayça Zeynep KUTLU, Pınar Saner DEMİR

Endotrophin levels in clinically-stable chronic obstructive pulmonary disease

Aim: Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation and permanent airflow limitations due to stenosis of the small airways. The role of the extracellular matrix (ECM) structure and its reshaping is gaining importance. Endotrophin is a division product formed during construction of type VI collagen. The aim of this study was to research the correlation between endotrophin and the stable COPD pathophysiology. Materials and Methods: The study included 90 clinically-stable COPD patients and 38 participants without COPD. The demographic data, respiratory function tests and endotrophin levels of patients were recorded and statistically evaluated. Results: Endotrophin levels were significantly high in COPD patients compared to healthy controls (p

PDF

___

1. Bidan CM, Veldsink AC, Meurs H,et al. Airway and extracellular matrix mechanics in COPD. Front. Physiol 2015;6:346.
2. Karsdal MA, Nielsen SH, Leeming DJ, et al. The good and the bad collagens of fibrosis – Their role in signaling and organ function. Adv Drug Deliv Rev 2017;121:43-56.
3. Cescon M, Gattazzo F, Chen P, et al. Collagen VI at a glance. J Cell Sci 2015;128:3525-31.
4. Bober M, Enochsson C, Collin M, et al. Collagen VI ıs a subepithelial adhesive target for human respiratory tract pathogens. J Innate Immun 2010;2:160-6.
5. Lamande SR, Morgelin M , Adams EN. The C5 domain of the collagen VI α3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells. J Biol Chem 2006;281:16607-14.
6. Aigner T, Hambach L, Söder S, et al. The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion. Biochem Biophys Res Commun 2002;290:743-8.
7. Kai Sun K, Park J, Gupta O, et al. Endotrophin triggers adipose tissue fibrosis and metabolic dysfunction. Nat Commun 2014;5:1-12.
8. Park J, Scherer PE. Adipocyte-derived endotrophin promotes malignant tumor progression. J Clin Invest 2012;122:4243-56.
9. Rannow SR, Sand JM, langholm L.L, et al. Type IV collagen turnover is predictive of mortality in COPD: a comparison to fibrinogen in a prospective analysis of the ECLIPSE cohort. Respir Res 2019;20: 63.
10. Schumann DM, Leeming D, Papakonstantinou E, et al. Collagen degradation and formation are elevated in exacerbated COPD compared with stable disease. Chest 2018;154:798-807.
11. Stolz D, Leeming DJ, Kristensen JHE, et al. Systemic biomarkers of collagen and elastin turnover are associated with clinically relevant outcomes in COPD. Chest 2017;151:47-59.
12. Sand JM, Leeming DJ, Byrjalsen I, et al. High levels of biomarkers of collagen remodeling are associated with increased mortality in COPD - results from the ECLIPSE study. Respir Res 2016;17:125.
13. Sand JM, Martinez G, Midjord AK et al. Characterization of serological neo-epitope biomarkers reflecting collagen remodeling in clinically stable chronic obstructive pulmonary .Clinical Biochemistry 2016;49:1144-51.
14. Sand JM , Knox AJ, Lange P. Accelerated extracellular matrix turnover during exacerbations of COPD. Respir Res 2015;16: 69.
15. Leeming DJ, Sand JM, Nielsen MJ. Serological ınvestigation of the collagen degradation profile of patients with chronic obstructive pulmonary disease or ıdiopathic pulmonary fibrosis. Biomark Insights 2012;7:119-26.
16. Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. European Respiratory J 2017;49:1700214.
17. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158:1384-7.
18. Zhao Y, Gu X, Zhang N, et al. Divergent functions of endotrophin on different cell populations in adipose tissue. Am J Physiol Endocrinol Metab 2016;31:952- 63.
19. Gan WQ, Man SF, Senthilselvan A,et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59: 574-80.
20. Thomsen M, Ingebrigtsen TS, Marott JL, et al. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. JAMA 2013;309:2353-61.
21. Deng ZC, Zhao P, Cao C, et al. C-reactive protein as a prognostic marker in chronic obstructive pulmonary disease. Exp Ther Med 2014:7;443-6.
22. Yoldemir SA, Arman Y, Akarsu M, et al .Correlation of glycemic regulation and etrophin in patient with types 2 diabetes ; pilot study. Diabetol Metab Syndr 2021:13;9.